SCHEMBL6994865

SCHEMBL6994865

COc1cc2nccc(Nc3ccc4c(c3)NCC4)c2cc1C#N

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 8/20 0.52
GAK O14976 6/20 0.48
RIPK2 O43353 4/20 0.48
COQ8A Q8NI60 4/20 0.48
NLK Q9UBE8 4/20 0.48
SRC P12931 5/20 0.46
BMPR1B O00238 1/20 0.46
EPHB6 O15197 1/20 0.46
ABL1 P00519 1/20 0.46
LCK P06239 1/20 0.46
EPHA1 P21709 1/20 0.46
EPHA8 P29322 1/20 0.46
ACVR1 Q04771 1/20 0.46
MAP2K5 Q13163 1/20 0.46
PDGFRA P16234 1/20 0.42
ERBB2 P04626 4/20 0.42
MET P08581 1/20 0.42
AXL P30530 1/20 0.42
MAPKAPK2 P49137 1/20 0.39
MAP2K1 Q02750 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4455183 0.80 EGFR (0.69) EGFRSRCERBB2MAP2K1
SCHEMBL6998602 0.76 MAP2K1 (0.62) EGFRSRCERBB2MAP2K1
SCHEMBL6997360 0.73 MAP2K1 (0.64) EGFRSRCERBB2MAP2K1
SCHEMBL4448819 0.73 EGFR (0.62) EGFRSRCERBB2MAP2K1
SCHEMBL6989870 0.72 EGFR (0.49) EGFRGAKSRCERBB2MAP2K1
SCHEMBL19957128 0.72 MET (0.52) EGFRSRCPDGFRAERBB2MET
SCHEMBL21106121 0.71 EGFR (0.79) EGFRGAKRIPK2COQ8ANLK
SCHEMBL4450574 0.71 MAP2K1 (0.58) EGFRSRCERBB2MAP2K1
SCHEMBL30017094 0.69 FGFR2 (0.61) EGFRGAKRIPK2COQ8ANLK
SCHEMBL14217352 0.68 EGFR (0.45) EGFRSRCERBB2METAXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1117659-B1 SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN TYROSINE KINASES INHIBITORS WYETH CORP (US) 2003-12-03 EP disclosed
US-6288082-B1 COMPOUNDS SUCH AS 6,7-DIETHOXY-4-(INDAN-5-YLAMINO) -QUINOLINE-3-CARBONITRILE USED AS ANTINEOPLASTIC AGENTS AND IN THE TREATMENT OF POLYCYCSTIC KIDNEY DISEASE AMERICAN CYANAMID COMPANY 2001-09-11 US disclosed
EP-1117659-A1 SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN TYROSINE KINASES INHIBITORS American Cyanamid Company (US) 2001-07-25 EP disclosed
WO-2000018761-A1 SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN TYROSINE KINASES INHIBITORS AMERICAN CYANAMID COMPANY (US) 2000-04-06 WO disclosed